Kevin Crowley Email & Phone Number

New Haven, Connecticut, Us

I have led CI’s investments in Perosphere, Populi, Enertiv, Enko, Veradermics, Torigen Pharmaceuticals, DeepLook Medical, Cara Therapeutics, Athletic Brewing, HistoRx, Oxford Performance Materials, Solias Lighting, UConn Innovation Fund, Carogen, Wellinks, and others. I currently serve on the boards of many CI investments. I also manage CI's Venture Debt program. In addition to my duties managing equity investments and sitting on boards, I previously managed the $50 million Connecticut BioScience Facilities Fund, which invested in the build-out of wet laboratory space and funds equipment purchases through loan/debt vehicles. This program had only one loss in its history and supported over a dozen bioscience companies in Connecticut. Hundreds of thousands of square feet of laboratory space were created with help from the fund. The fund's return for CI have been significant (interest and warrants) over its life allowing reinvestment of the proceeds into additional companies. Upon the launch of the State's $100MM Stem Cell fund, I was responsible for coordination, contracting, and first distributions of the fund -one of the first in the Country to make investments. In 2012 I also took over Connecticut Innovations PreSeed Program, a program designed to make very early stage investments in new companies. The PreSeed Program is a feeder to CI's larger funds and one of the most successful in the country. CI has made over 100 investments through the fund (over 300 closings and tranches). Other past experience included managing CI's two incubator laboratories at 25 Science Park in New Haven.

Danbury, Ct, Us

Perosphere's PoC Coagulometer provides an unprecedented global view of coagulation status where and when it's needed the most, in emergency care. The PoC Coagulometer is the only diagnostic tool that effectively and swiftly monitors clotting processes across drug classes-including DOACs. Adopting the PoC Coagulometer as a new standard of care in the ER holds potential for improved efficiency, significant cost savings, and better patient outcomes due to fast diagnosis and related appropriate treatment decisions.

Mystic, Ct, Us

Enko designs safe and sustainable solutions to farmers’ biggest crop threats today, from pest resistance to new diseases. By applying the latest drug discovery and development approaches from pharma to plants, Enko is bringing an innovation model to agriculture and meeting farmers’ evolving needs.

New Haven, Ct, Us

VeraDermics is a dermatology company that creates novel drug delivery mechanisms for a pain-free cure for skin conditions such as warts. It offers a dissolvable microneedle patch solution that administers immunotherapy without any pain, a treatment that stimulates the body’s own immune system to fight off the wart virus.

Norwalk, Connecticut, Us

BioWave is a non-opioid, FDA cleared, patented, Smarter Pain Blocking Technology that is designed to block pain at the source. It goes beyond old-fashioned TENS products. BioWave is used by over 120 professional sports teams NFL, NHL, NBA, and MLB, and over 160 major NCAA college athletic programs. The BioWaveGO product is a new, non-prescription version of the non-opioid, FDA cleared technology that is now for sale direct to consumers that suffer from chronic pain.

Torigen’s experimental autologous cancer vaccine works by generating a vaccine from a patient's (pet's) deactivated tumor cells to stimulate the immune system against specific tumor-associated antigens found on the outside surface of the tumor cells

Los Angeles, Ca, Us

Trebel is the only free music download app with offline listening.Trebel enables music fans to download the best songs in the world for free and play those songs offline. Other companies offer excellent paid services, but there are more than 2.5 billion smartphone users worldwide who don't pay for music. We provide an answer for anyone who wants an offline option for free music on their smartphone.

New Haven, Connecticut, Us

At Wellinks, we leverage our empathic and innovative spirit as a catalyst for creating a constellation of care around our members. Through virtual-first human-centered care, we empower greater outcomes for those living with chronic respiratory disease.

Farmington, Connecticut, Us

CaroGen Corporation is an emerging vaccine immunotherapy company employing a virus-like vesicle (VLV) platform technology developed at Yale University School of Medicine and exclusively licensed for the development and commercialization of vaccine immunotherapies worldwide. Our vision is to create different, potentially transformative first-in-class nanoparticle therapeutic vaccine immunotherapies designed to engage the body’s immune system to both recognize and fight off infectious diseases and cancer. The company is leveraging the VLV platform and developing a portfolio of vaccine candidates against the following infections/diseases:•Chronic Hepatitis B Viral Infection (CHB) in collaboration with Yale School of Medicine and Albany Medical College•Clostridium difficile, a bacterial infection, in collaboration with the University of Connecticut Medical School/Health Center•Zika Virus Infection in collaboration with the Center for Excellence for Vaccine Research (CEVR) at the University of ConnecticutThe hepatitis B program is CaroGen's lead program and has completed initial proof-of-concept testing in animals which was published in August 2015 in the Journal of Virology. Worldwide, approximately 240 million people live with CHB and 600,000 die each year from HBV-associated liver disease and cancer. The HBV program is undergoing optimization for selection of a clinical candidate capable of stimulating the immune system to multiple HBV target antigens.

A $1.5M fund between Connecticut Innovations, Webster Bank, and UConn devoted to funding early stage UConn related companies.

North Haven, Ct, Us

ICN is an innovative software-as-a-service (SaaS) company that electronically delivers and clears digital and paper coupons thru a single connection at the point-of-sale in grocery, drug and mass merchant retailers—collecting a processing fee for each incentive redeemed. ICN’s clearing network, based on two published and one pending patent has the potential to replace today’s highly manual, convoluted and fraud-prone process. And for the first time, this new technology will also provide manufacturers, media companies, and retailers with true "Real Time" redemption information for digital and paper the moment the incentive clears the retailer’s POS system.ICN successfully beta tested its digital solution in VG Food Centers, a 17 store grocery chain in Central Michigan. During the 60 days of evaluation, ICN’s incentive clearing system was fully vetted, processing millions of checkout transactions with an average response time of 150 milliseconds. With commitments from a significant number of retailers, ICN will be expanding aggressively to build its digital network.

New Haven, Connecticut, Us

MinInvasive Ltd. is a privately held MedTech company which has developed an Arthroscopic Device for Rotator Cuff Repair (RCR)

Affinimark Technologies Inc., a private bioscience company based in New Haven, Connecticut, develops proprietary medical diagnostic products addressing market opportunities and serious unmet medical/surgical needs. Its lead product, CerebrostripTM, is a strip-based diagnostic test, derived from Affinimark’s own cutting edge research, that will quickly and cost-effectively provide a definitive determination whether a patient has suffered a cerebrospinal fluid leak as a result of surgery or trauma. No such product is currently available, resulting in significant risk to the patient and cost to the healthcare system.

Oil Purification Systems, Inc. (OPS) is the developer of the OPS-1, a patented onboard oil refining system that streamlines oil maintenance routines for large vehicles and industrial equipment.A recognized innovator in the field of oil bypass filtration, the company has developed an onboard oil refining system that is compact, lightweight, easy to install, and capable of filtering solid and liquid contaminants from engine oil so effectively that scheduled oil changes are no longer necessary. Founded in 2002, OPS has established the OPS-1 as a proven solution for companies in the trucking, construction, mining, public transportation, waste management and numerous other industries.

Precipio is a cancer diagnostics reference laboratory, delivering the latest in advanced diagnostics and personalized medicine. Our goal is to assist oncologists in providing the best care for their patients. At the intersection of academia, cancer research, and diagnostics, we connect physicians with world-renown pathologists at the Yale School of Medicine. At Precipio, our customers and their patients benefit from the most accurate, expert diagnosis. We provide our customers exclusive access to some of the most innovative tests in the field of molecular diagnostics, developed through cutting edge research, and the ongoing pursuit and refinement of the science of personalized medicine.

South Windsor, Ct, Us

OPM was founded in 2000 with a simple purpose: to exploit a highly advanced molecule called poly-ether-ketone-ketone (PEKK). PEKK is an ultra high performance thermoplastic technology platform that presents a vast array of business opportunities. Whether working to produce green energy, making planes lighter, making silicon chips faster or making medical products that improve human health, OPM has been at the forefront of the world's deepest material challenges, helping to break down the barriers limiting human development and sustainability

A fully owned corporation of Connecticut Innovations for real estate transactions and management of Connecticut Innovations incubator laboratories.

Stamford, Connecticut, Us

Cara possesses both near-term clinical development opportunities, combined with proprietary approaches to developing first-in-class novel therapeutics. Cara's first patented compound, CR665, has entered clinical testing for acute pain. This best-in-class compound possesses unique analgesic and anti-inflammatory activities appropriate for multiple therapeutic applications. In addition, Cara aims to develop a future pipeline of first-in-class molecules at novel analgesic and anti-inflammatory targets using its proprietary drug screening technology.

Solais Lighting is a market-driven manufacturing company, passionate about improving environments through innovative LED lighting solutions. As an industry leader in LED lamp technology, Solais uses its innovation capability to continually develop products to meet market demands. Solais has a highly regarded and dedicated executive team, consisting of leading professionals from all facets of the lighting industry, including: solid-state lighting research, product development, manufacturing, distribution and procurement.

HistoRx is developing unique diagnostic solutions to unlock new approaches to individualized patient care. HistoRx’s proprietary AQUA® technology uses quantitative IHC to deliver objective and reproducible multiparametric analysis of proteins in routine clinical specimens, providing new insights into cancer treatment. The Company is applying this expertise to build a proprietary pipeline of diagnostic candidates and to help biopharmaceutical customers advance their drug development programs.

SSI, founded in 1998 and sold to a publicly traded EMR in 2011, was a disease-state management company dedicated to enhancing the quality of care provided to patients who require long-term therapy for chronic disease management. SSI’s software products or “e-suite of applications”, CoagClinic, CholesterolClinic, DMClinic and CHFClinic, provide health care professionals the tools they need to effectively administer chronic disease therapy while improving outcomes, reducing overhead costs and optimizing provider remuneration.

Board of Directors, With RemoTV you can use your cellphone to access videos or MP3s on your home computer. Just install the desktop application on your home PC and import your media. Create channels for yourself and others to view and then sign up, kick back, and enjoy the best new mobile entertainment available. Too advanced for its time, this company did not have a successful exit. My only unsuccessful venture to date.

Rib-X Pharmaceuticals, Inc. is focused on the design and development of novel small-molecule antibiotics for the treatment of antibiotic-resistant infections in hospital and community settings.

Ran the State's Office of BioScience, an entitiy created to act as the one point of contact with the state's biotechnology and phara companies. Focused on policy, financing, negotiation of incentives, program development and devlopment projects of up to $1 Billion.As the former Director of Business Recruitment I was responsible for the negotiation of the State's most complex competitive Fortune 500 development, expansion and relocation projects.

Mba, Strategic Planning And Organizational Theory

Bs, Management

Education record